IM Cannabis Corp (IMCC) is an international cannabis company trading on the NASDAQ. The stock is currently priced at $0.88 with a market capitalization of $5.1M and trailing twelve-month revenue of $38.9M. The company reports a gross margin of 17.7%. View SEC filings ↗
Market Cap
$5.1M
Volume
43.8K
Prev Close
$0.85
52W High
$62.40
52W Low
$0.79
P/S Ratio
0.13
Shares Out
5.9M
Revenue
$38.9M
Gross Margin
17.7%
Cash
$1.9M
IMCC Price Chart
Latest Quarterly Results
In Q2 2025, IM Cannabis Corp reported revenue of $9.0M. Gross margin was 27.0%. The net loss was $138.0K. The company ended the quarter with $564.9K in cash.
| IMCC | Q2 2025 | YoY |
|---|---|---|
| Revenue | $9.0M | — |
| Gross margin | 27.0% | — |
| Net income | -$138.0K | — |
| Operating cash flow | — | — |
| Cash & equivalents | $564.9K | — |
| Total debt | — | — |
Source: SEC filings, in USD; quarters are calendar quarters of the period end. Latest filing: 20-F, filed Mar 30, 2026 ↗. Next report expected around Mar 30, 2027 (estimate).
Trading Data
Valuation Metrics
Financial Highlights
View Full FinancialsIMCC Key Takeaways
- IM Cannabis Corp (IMCC) trades at $0.88 with a market cap of $5.1M, ranking #52 among 71 cannabis stocks.
- Trailing twelve-month revenue is $38.9M, growing +1.30% year-over-year.
- Gross margin stands at 17.7% — thin margins indicating cost pressures.
- Balance sheet shows $1.9M cash against $10.9M debt — net debt position.
- Price-to-Sales ratio of 0.13x — below sector median, potentially undervalued.
- Ranked #1 by market cap in the International sector. Trades on the NASDAQ exchange.
IMCC Stock Analysis
IM Cannabis Corp (IMCC) is an international cannabis company listed on the NASDAQ exchange, headquartered in IL. With a current share price of $0.88 and a market capitalization of $5.1M, IMCC ranks #52 out of 71 publicly traded cannabis stocks tracked on Cannabismarketcap.
From a fundamental perspective, IM Cannabis Corp reports trailing twelve-month revenue of $38.9M, representing growth of +1.30% year-over-year. The company maintains a gross margin of 17.7%, which reflects the cost pressures common to emerging cannabis operators. At a price-to-sales multiple of 0.13x, the stock appears attractively valued relative to its revenue base.
The company's balance sheet shows $1.9M in cash and equivalents against $10.9M in total debt, leaving net debt of $8.9M. Investors looking for a deeper dive can explore IMCC's full financial statements including quarterly breakdowns and balance sheet history.
IMCC currently trades within a 52-week range of $0.79 to $62.40. Average daily trading volume stands at 43.8K shares. The company employs approximately 55 people.
Corporate Information
Share Structure
IMCC Price History
Investment Snapshot
Programmatic analysis based on available financial data. Not investment advice.
Ranked #52 of 71 by market cap ($5.1M). Sector median: $32.9M.
Net debt: $8.9M ($1.9M cash, $10.9M debt). Gross margin at 17.7%.
Revenue growth at +1.3% YoY. Sector median: +1.6%.
P/S ratio of 0.13x vs sector median of 0.71x. Potentially undervalued.
Cannabis Industry Context
Cannabis Industry Overview
The global cannabis market extends well beyond North America, with an increasing number of countries establishing medical cannabis programs and, in some cases, moving toward regulated adult-use frameworks. Germany has emerged as the largest medical cannabis market in Europe and is pursuing a landmark recreational legalization model that could set precedent for the broader European Union. Other European markets with active medical cannabis programs include Poland, the Czech Republic, Italy, Portugal, and the United Kingdom. In the Asia-Pacific region, Australia and Thailand have developed distinct regulatory approaches, with Thailand becoming the first Southeast Asian country to decriminalize cannabis. Latin American markets — particularly Colombia, Uruguay, and Mexico — offer low-cost cultivation environments and varying degrees of legal market structure. International cannabis companies navigate a complex web of country-specific regulations, EU-GMP certification requirements, import/export licensing, and currency risk. Investors in this segment evaluate geographic diversification, regulatory moat in early-mover markets, supply agreements with established healthcare distributors, and the timeline for market maturation in each jurisdiction.
IM Cannabis Corp in the International Cannabis Landscape
IM Cannabis Corp (IMCC) currently ranks #1 out of 4 publicly traded international cannabis companies by market capitalization, with a market cap of $5.1M. The company reports trailing-twelve-month revenue of $38.9M, placing it above the sector median of $19.5M. The international cannabis sector comprises 4 tracked companies, reflecting the focused competitive landscape within this segment of the cannabis industry.
The top companies in the international cannabis sector by market capitalization are IM Cannabis Corp (IMCC) at $5.1M, Blueberries Medical Corp (BBRRF) at $4.5M, and Akanda Corp (AKAN) at $2.1M. As the sector leader by market capitalization, IM Cannabis Corp plays a significant role in setting investor expectations and operational benchmarks for the group.
Key Metrics at a Glance
Regulatory & Risk Considerations
All cannabis investors should be aware that federal legalization status in the United States remains uncertain. While cannabis is legal for medical use in the majority of US states and for adult use in a growing number of jurisdictions, it remains classified as a Schedule I controlled substance at the federal level. This creates material legal, financial, and operational risks across the industry. International cannabis operators like IM Cannabis Corp must navigate a patchwork of country-specific regulations that can change rapidly as governments refine their cannabis policies. Import/export licensing, EU-GMP certification requirements, and in-country distribution agreements all require significant time and capital investment, with no guarantee of regulatory continuity.
Currency risk is a material consideration for international operators generating revenue across multiple jurisdictions. Political risk also varies significantly by country — regulatory rollbacks, changes in government, or shifts in public sentiment can disrupt market access. Companies operating in emerging cannabis markets may also face challenges around intellectual property protection, local partner reliability, and the development of compliant supply chains in jurisdictions with limited cannabis-specific infrastructure.
Compare IMCC With Peers
Related International Stocks
Frequently Asked Questions
What is IM Cannabis Corp's (IMCC) stock price today?▼
IM Cannabis Corp (IMCC) stock is currently trading at $0.88 per share on the NASDAQ exchange. This represents a daily gain of +3.00% ($0.0255) from the previous closing price of $0.85. Over the past 52 weeks, IMCC has traded between a low of $0.79 and a high of $62.40, placing the current price at approximately -99% from its annual high. The stock has a market capitalization of $5.1M, making it a notable cannabis companies tracked by Cannabismarketcap. IM Cannabis Corp operates in the International sector, serving the broader cannabis industry.
What is IM Cannabis Corp's market capitalization?▼
IM Cannabis Corp (IMCC) has a current market capitalization of $5.1M, calculated by multiplying its 5.9M shares outstanding by the current stock price of $0.88. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places IM Cannabis Corp among the small-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $14.0M, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.
Is IM Cannabis Corp profitable?▼
IM Cannabis Corp (IMCC) currently reports a gross margin of 17.7%, which means the company retains 17.7 cents of every revenue dollar after direct costs of goods sold. On trailing twelve month revenue of $38.9M, this translates to an estimated gross profit of approximately $6.9M. Profitability is a critical factor in the cannabis industry, where many companies are still investing heavily in growth and regulatory compliance. Investors should review the full income statement, cash flow trends, and operating expense breakdown on Cannabismarketcap for a complete picture of IM Cannabis Corp's financial health.
What is IM Cannabis Corp's annual revenue?▼
IM Cannabis Corp (IMCC) reports trailing twelve month (TTM) revenue of $38.9M, reflecting the total sales generated by the company over the most recent four quarters. Revenue has changed +1.30% year-over-year, indicating growth momentum relative to the prior period. The current price-to-sales ratio is 0.13x, which means investors are paying $0.13 for every $1 of annual revenue — a relatively low valuation in the context of the cannabis sector. Revenue is one of the most closely watched metrics for cannabis companies, as many are still scaling operations in a rapidly evolving regulatory environment. View the full income statement and quarterly revenue breakdown on Cannabismarketcap for detailed trend analysis.
How many employees does IM Cannabis Corp have?▼
IM Cannabis Corp currently employs approximately 55 people across its operations. As an international cannabis company headquartered in IL, its workforce supports activities spanning related business functions. Based on trailing twelve month revenue of $38.9M, this equates to approximately $708.0K in revenue per employee, which is a useful efficiency metric for comparing operational productivity across cannabis companies. Employee count is an important indicator of a company's operational scale and its capacity for growth in an industry that remains highly labor-intensive due to regulatory requirements.
What exchange is IMCC listed on?▼
IM Cannabis Corp trades under the ticker symbol IMCC on the NASDAQ exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts. The company has been publicly listed since 1997-02-13, giving it a track record in the public markets that investors can analyze for long-term trends. The stock sees average daily trading volume of approximately 43.8K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.
What is IM Cannabis Corp's gross margin?▼
IM Cannabis Corp (IMCC) has a gross margin of 17.7%, which represents the percentage of revenue the company retains after paying for the direct cost of goods sold. On trailing twelve month revenue of $38.9M, this translates to an estimated gross profit of approximately $6.9M. Gross margin is a critical profitability indicator in the cannabis industry, where companies face unique cost pressures from regulatory compliance, testing requirements, and the tax burden of IRC Section 280E (which prevents cannabis companies from deducting standard business expenses). A thin gross margin like IM Cannabis Corp's suggests the company has pricing power and operational efficiency relative to peers.
What is IMCC's 52-week trading range?▼
IM Cannabis Corp (IMCC) has traded between a 52-week low of $0.79 and a 52-week high of $62.40, with the current price of $0.88 sitting approximately -99% from the annual high. This range represents a spread of $61.61 (7771% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.
What is IM Cannabis Corp's cash position and debt level?▼
IM Cannabis Corp (IMCC) holds $1.9M in cash and equivalents on its balance sheet, set against $10.9M in total debt. This gives the company a net debt position of $8.9M. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.
How many shares outstanding does IM Cannabis Corp have?▼
IM Cannabis Corp (IMCC) currently has 5.9M shares outstanding, which when multiplied by the current stock price of $0.88 gives the company its market capitalization of $5.1M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.
Embed IMCC Widget
Add the IMCC price widget to your website or blog:
<iframe src="https://cannabismarketcap.io/embed/imcc" width="320" height="180" frameborder="0" style="border-radius:8px;border:1px solid #415a77"></iframe>Data updates every 2 minutes. Free for non-commercial use.
Disclaimer
The information on this page is provided for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Cannabismarketcap is not a registered broker-dealer or investment advisor. All data, including stock prices, market capitalizations, financial metrics, and analysis for IM Cannabis Corp (IMCC), is provided “as is” without warranty of any kind. Past performance does not guarantee future results. Cannabis stocks are highly volatile and carry significant risk, including the potential for total loss of investment. Marijuana remains illegal under federal law in the United States. Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions. Data may be delayed or inaccurate. See our terms of service and privacy policy for more information.